UK small-cap RNS · 8 Dec 2025
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus the ones that are part of a situation. Not investment advice.
Sort: Newest · Largest companies
-
16:30
-
11:50
Tulu Kapi Project Finance and Launch Update· As per the Company's announcement of 20 October 2025, of the total Project funding requirement of US$340 million:Moved: Tulu Kapi project financing and construction: Debt approved; equity oversubscribed; closing pending → Debt documented; equity-risk gap partly covered by term sheets
-
07:00
PureTech Health PRTC £268mSuccessful FDA Meeting; IPF Phase 3 in 1H26PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary FibrosisMoved: Meet FDA on deupirfenidone Phase 3 design by end of Q3 2025: pending → delivered – The End-of-Phase 2 meeting with the FDA on the deupirfenidone Phase 3 design has been completed, though the announcement is dated after the Q3 2025 deadline. · Initiate Phase 3 deupirfenidone IPF trial (end-2025, then H1 2026, then early Q3: pending → on_track – Phase 3 SURPASS-IPF start is guided for H1 2026, within the existing window (dossier deadline is early Q3 2026). · Close Celea financing by H1 2026 (originally early 2026): pending → on_track – Celea expects to finalize financing in early 2026, within the H1 2026 deadline, to support the Phase 3 start.
-
07:00
Thruvision Group THRU £8.5mImminent contract awardA Notice of Intent to Award for two 8116 cameras at a Pacific Northwest airport is a small first step toward the several year-end awards flagged at interims, easing cash pressure. Contract value is not stated and the award is not yet final.Balance-sheet stress / refinancing +31.0% on the dayMoved: Going concern and cash runway: Cash £1.65m; orders needed to avoid fundraise → First year-end order notice received; value unstated
-
07:00
Private Placement in UK and NorwayRaises about £3.66m through UK and Norwegian placings at a 10% discount, issuing 100.9m new shares. The CEO concedes 'painful dilution', but the money funds uranium permits, Puglia solar construction and ICSID legal costs.Moved: new: Dilutive placing to fund projects – Completed; UK shares admit around 16 December · Tunisian authorities dispute and oil confiscation: Unauthorised sale; legal remedies being pursued → ICSID arbitration; legal team expanded · Italian uranium exploration permits: Applications accepted by Lombardy; EIA being prepared → Applications accepted; EIAs being prepared; funded